Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
Generally very positive experience. Our management trust people who can make real contributions to the team
O que você mais gosta nos lideres?
Our leaders care about us above the business
Qual é a melhor parte das suas compensações?
Stock options, Heath insurance and equity
Quais são algumas das melhores coisas da sua equipe?
Energy and Dedication of the team
O que faz você mais feliz no trabalho?
Making impact and advance career
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
Management are supportive They take a personal approach
Other Employee Reviews for Karyopharm Therapeutics
×